C J Thompson
Overview
Explore the profile of C J Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
303
Citations
4255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donald D, Sherlock M, Thompson C
Endocr Oncol
. 2023 Jul;
2(1):R78-R89.
PMID: 37435459
Hyponatraemia is a common electrolyte abnormality seen in a wide range of oncological and haematological malignancies and confers poor performance status, prolonged hospital admission and reduced overall survival, in patients...
2.
Forde H, Davenport C, Rochfort K, Wallace R, Durkan E, Agha A, et al.
Diabetes Res Clin Pract
. 2022 Jun;
189:109936.
PMID: 35662613
Aims: Cardiovascular disease (CVD) is the leading cause of mortality in type 2 diabetes mellitus (T2DM). Epidemiological studies suggest serum Osteoprotegrin (OPG)/Tumour-necrosis-factor-related-apoptosis-inducing- ligand (TRAIL) ratio may be a useful marker...
3.
OConnor-Byrne N, Glavey S, Tudor R, Murphy P, Thompson C, Quinn J
Exp Hematol Oncol
. 2019 Feb;
8:4.
PMID: 30733892
The development of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) is well recognised in multiple myeloma (MM). SIADH, due to either MM or Bortezomib can be hazardous...
4.
Crowley R, Thompson C
Expert Rev Endocrinol Metab
. 2018 Oct;
1(4):537-547.
PMID: 30290457
The syndrome of inappropriate antidiuresis is the most common cause of euvolemic hyponatremia and complicates a wide spectrum of diseases and neurosurgical conditions. The syndrome is characterized by clinical euvolemia,...
5.
Ibie C, Knott R, Thompson C
Drug Dev Ind Pharm
. 2018 Sep;
45(1):67-75.
PMID: 30252537
A significant barrier to oral insulin delivery is its enzymatic degradation in the gut. Nano-sized polymer-insulin polyelectrolyte complexes (PECS) have been developed to protect insulin against enzymatic degradation. Poly(allylamine) (Paa)...
6.
Dineen R, Bogdanet D, Thompson D, Thompson C, Behan L, McKay A, et al.
QJM
. 2018 Mar;
110(12):821-827.
PMID: 29590494
Background: Lithium is the mainstay of treatment for bipolar disorder, mania and an augmentation therapy in patients with treatment resistant depression. It has a narrow therapeutic index, with recognized adverse...
7.
Garrahy A, Hannon A, Zia-Ul-Hussnain H, Williams D, Thompson C
Eur J Clin Pharmacol
. 2017 Nov;
74(2):245-246.
PMID: 29147803
No abstract available.
8.
Zia-Ul-Hussnain H, Farrell M, Looby S, Tormey W, Javadpour M, McConkey S, et al.
Ir J Med Sci
. 2017 Jul;
187(2):461-464.
PMID: 28733940
Introduction: Pituitary tuberculosis is an uncommon cause of sellar mass [1]; the estimated prevalence worldwide is not known, and there have been no reports of the condition occurring in Ireland....
9.
Goertzen A, Zhang X, Liu C, Kozlowski P, Retiere F, Ryner L, et al.
Med Phys
. 2017 May;
39(7Part4):4640.
PMID: 28516645
Silicon photomultiplier (SiPM) detectors are rapidly becoming the detector of choice for research and development of new detectors for positron emission tomography (PET) due to their combination of high gain,...
10.
Salehmohamed M, Griffin M, Branigan T, Cuesta M, Thompson C
Ir J Med Sci
. 2017 May;
187(1):69-74.
PMID: 28474235
Background: Patients taking corticosteroids for immune suppression are vulnerable to adrenal crisis during acute illness or if steroids are stopped abruptly. Although patients treated for adrenal failure in endocrine units...